PEGFILGRASTIM

PEGFILGRASTIM was reported 11978 times

PEGFILGRASTIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UNINTENTIONAL MEDICAL DEVICE REMOVAL 8999 0.7771
1 DEVICE ADHESION ISSUE 11933 0.7770
2 COMPUTERISED TOMOGRAM THORAX 39 0.6500
3 DEVICE ELECTRICAL FINDING 409 0.5777
4 MAGNETIC RESONANCE IMAGING 71 0.5504
5 APPLICATION SITE EXTRAVASATION 40 0.5333
6 APPLICATION SITE HAEMORRHAGE 1397 0.5110
7 DEVICE MONITORING PROCEDURE NOT PERFORMED 36 0.3750
8 AORTIC WALL HYPERTROPHY 15 0.3659
9 COLONY STIMULATING FACTOR THERAPY 75 0.3623
10 BASAL GANGLION DEGENERATION 34 0.3617
11 NUCLEAR MAGNETIC RESONANCE IMAGING 55 0.3313
12 APPLICATION SITE BRUISE 277 0.2847
13 COMPUTERISED TOMOGRAM 37 0.2681
14 DEVICE OCCLUSION 3368 0.2391
15 APPLICATION SITE DISCOMFORT 420 0.2336
16 OCCUPATIONAL EXPOSURE TO PRODUCT 1413 0.2196
17 AORTITIS 137 0.1997
18 DEVICE PHYSICAL PROPERTY ISSUE 1394 0.1818
19 DEVICE USE ERROR 6057 0.1741
20 DEVICE POWER SOURCE ISSUE 486 0.1663
21 APPLICATION SITE INJURY 27 0.1421
22 INTERCEPTED PRODUCT PREPARATION ERROR 1575 0.1278
23 APPLICATION SITE MASS 35 0.1277
24 TISSUE INFILTRATION 37 0.1254
25 INVESTIGATION 392 0.1250
26 DEVICE ALARM ISSUE 214 0.1178
27 NEUROBLASTOMA RECURRENT 23 0.1133
28 INCORRECT DISPOSAL OF PRODUCT 359 0.1104
29 COMPUTERISED TOMOGRAM THORAX ABNORMAL 74 0.1077
30 DEVICE BATTERY ISSUE 70 0.1064
31 DEVICE MALFUNCTION 6943 0.0987
32 APPLICATION SITE HAEMATOMA 18 0.0984
33 NEUTROPHIL COUNT ABNORMAL 277 0.0979
34 BONE MARROW NECROSIS 19 0.0812
35 ARTERITIS 49 0.0775
36 ANAESTHESIA 27 0.0740
37 NAIL BED INFLAMMATION 23 0.0721
38 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 66 0.0655
39 TRIPLE NEGATIVE BREAST CANCER 43 0.0639
40 NEUTROPENIC INFECTION 56 0.0585
41 APPLICATION SITE PAIN 1273 0.0577
42 DEVICE ISSUE 5176 0.0577
43 FEBRILE NEUTROPENIA 3819 0.0575
44 DEVICE PLACEMENT ISSUE 201 0.0561
45 DEVICE FAILURE 838 0.0550
46 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10265 0.0506
47 BONE PAIN 2947 0.0503
48 ALOPECIA TOTALIS 16 0.0486
49 ACCIDENTAL EXPOSURE TO PRODUCT 5007 0.0485
50 WHITE BLOOD CELL COUNT ABNORMAL 307 0.0481
51 UTERINE ENLARGEMENT 38 0.0479
52 INTERCEPTED PRODUCT ADMINISTRATION ERROR 356 0.0464
53 PSYCHOLOGICAL TRAUMA 400 0.0463
54 INTERCEPTED DRUG ADMINISTRATION ERROR 20 0.0456
55 NASAL MUCOSAL DISORDER 24 0.0412
56 PRODUCT COMMUNICATION ISSUE 352 0.0399
57 HAIR DISORDER 318 0.0386
58 ALOPECIA AREATA 67 0.0382
59 NEUTROPENIC COLITIS 78 0.0377
60 DRUG DELIVERY SYSTEM MALFUNCTION 187 0.0365
61 NEUTROPENIC SEPSIS 258 0.0361
62 FEBRILE INFECTION 42 0.0357
63 PSYCHOGENIC SEIZURE 31 0.0332
64 DEVICE LEAKAGE 1404 0.0323
65 SPLENIC RUPTURE 53 0.0322
66 HAIR COLOUR CHANGES 401 0.0322
67 HYPERLEUKOCYTOSIS 28 0.0316
68 MADAROSIS 367 0.0316
69 HYPOCHROMIC ANAEMIA 32 0.0316
70 TRANSITIONAL CELL CARCINOMA 40 0.0308
71 STREPTOCOCCAL SEPSIS 36 0.0304
72 HAIR TEXTURE ABNORMAL 404 0.0302
73 PSEUDOMONAL SEPSIS 52 0.0297
74 CHEMOTHERAPY 112 0.0296
75 STAPHYLOCOCCAL BACTERAEMIA 127 0.0292
76 FEBRILE BONE MARROW APLASIA 123 0.0289
77 SYSTEMIC INFECTION 47 0.0283
78 KLEBSIELLA TEST POSITIVE 18 0.0276
79 PRODUCT PREPARATION ERROR 558 0.0271
80 DRUG DOSE OMISSION BY DEVICE 2121 0.0271
81 RECTAL FISSURE 17 0.0270
82 CATHETER SITE RELATED REACTION 20 0.0267
83 LYMPHADENECTOMY 26 0.0266
84 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 884 0.0261
85 SUBCLAVIAN VEIN THROMBOSIS 29 0.0255
86 WHITE BLOOD CELL DISORDER 67 0.0250
87 RADIOTHERAPY 47 0.0246
88 PSEUDOMONAL BACTERAEMIA 20 0.0234
89 CATHETER RELATED INFECTION 23 0.0227
90 LYMPHADENITIS 53 0.0219
91 INTERCEPTED MEDICATION ERROR 100 0.0216
92 NEUTROPHIL COUNT DECREASED 856 0.0210
93 DACRYOSTENOSIS ACQUIRED 27 0.0209
94 APLASIA 40 0.0204
95 CAPILLARY LEAK SYNDROME 42 0.0203
96 BODY TEMPERATURE ABNORMAL 37 0.0201
97 MASTECTOMY 35 0.0200
98 NEUTROPENIA 2689 0.0198
99 ATELECTASIS 188 0.0194
100 INCORRECT DOSE ADMINISTERED BY DEVICE 509 0.0194
101 TUMOUR PAIN 25 0.0190
102 LEUKOCYTOSIS 343 0.0189
103 SEROMA 24 0.0189
104 PERIPHERAL SENSORY NEUROPATHY 110 0.0188
105 NEEDLE ISSUE 513 0.0176
106 ALVEOLITIS ALLERGIC 18 0.0174
107 ENTEROCOLITIS INFECTIOUS 16 0.0173
108 THERAPEUTIC PROCEDURE 24 0.0171
109 MUCOSAL INFLAMMATION 440 0.0168
110 LYMPH NODE PAIN 31 0.0166
111 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 38 0.0163
112 TONGUE COATED 28 0.0162
113 SPLENIC INFARCTION 28 0.0160
114 PERIPHERAL MOTOR NEUROPATHY 22 0.0157
115 DEVICE MATERIAL ISSUE 33 0.0157
116 APPLICATION SITE DISCOLOURATION 61 0.0150
117 T-CELL LYMPHOMA 17 0.0148
118 UNDERDOSE 1054 0.0144
119 CULTURE URINE POSITIVE 20 0.0142
120 PULMONARY TOXICITY 100 0.0141
121 NEUTROPHIL COUNT INCREASED 143 0.0140
122 NAIL INFECTION 20 0.0139
123 DEVICE DEPLOYMENT ISSUE 177 0.0138
124 NEUROLOGICAL DECOMPENSATION 32 0.0138
125 BLOOD CULTURE POSITIVE 41 0.0137
126 DEVICE DELIVERY SYSTEM ISSUE 366 0.0134
127 APPLICATION SITE WARMTH 17 0.0133
128 VASCULAR DEVICE INFECTION 59 0.0130
129 DRUG DOSE OMISSION 2104 0.0127
130 CENTRAL VENOUS CATHETERISATION 38 0.0126
131 STENOTROPHOMONAS INFECTION 17 0.0125
132 APPLICATION SITE SWELLING 62 0.0124
133 BREAST CANCER RECURRENT 39 0.0123
134 CYSTITIS HAEMORRHAGIC 49 0.0121
135 LEFT VENTRICULAR DYSFUNCTION 80 0.0119
136 WHITE BLOOD CELL COUNT DECREASED 1284 0.0118
137 HEART RATE ABNORMAL 66 0.0118
138 WHITE BLOOD CELL COUNT INCREASED 452 0.0118
139 SMALL INTESTINAL PERFORATION 22 0.0117
140 NON-CARDIAC CHEST PAIN 37 0.0117
141 LEUKOPENIA 576 0.0115
142 LYMPHOEDEMA 79 0.0114
143 URINARY TRACT OBSTRUCTION 27 0.0114
144 BLOOD MAGNESIUM DECREASED 98 0.0113
145 METASTASES TO LYMPH NODES 76 0.0112
146 REFUSAL OF TREATMENT BY PATIENT 72 0.0110
147 BONE MARROW DISORDER 33 0.0109
148 IMPAIRED QUALITY OF LIFE 157 0.0109
149 KLEBSIELLA INFECTION 55 0.0109
150 ABDOMINAL TENDERNESS 54 0.0109
151 CATHETER SITE PAIN 28 0.0108
152 DYSAESTHESIA 33 0.0108
153 AXILLARY PAIN 16 0.0107
154 IMPETIGO 16 0.0107
155 ORAL CANDIDIASIS 141 0.0107
156 ESCHERICHIA BACTERAEMIA 25 0.0106
157 SMALL CELL LUNG CANCER 16 0.0106
158 STAPHYLOCOCCAL SEPSIS 51 0.0103
159 PANCYTOPENIA 575 0.0103
160 CATHETER SITE ERYTHEMA 22 0.0103
161 METASTASES TO CENTRAL NERVOUS SYSTEM 132 0.0102
162 LUNG INFILTRATION 90 0.0102
163 THROMBOCYTOPENIA 1138 0.0102
164 BLOOD CREATINE INCREASED 45 0.0102
165 JUGULAR VEIN THROMBOSIS 18 0.0101
166 TONGUE ULCERATION 34 0.0101
167 CLOSTRIDIAL INFECTION 34 0.0100
168 COLON CANCER METASTATIC 16 0.0099
169 PRODUCT STORAGE ERROR 862 0.0098
170 HYPERPYREXIA 41 0.0097
171 ESCHERICHIA SEPSIS 28 0.0097
172 MITRAL VALVE DISEASE 17 0.0096
173 PHLEBITIS 49 0.0096
174 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 21 0.0095
175 EMBOLISM 79 0.0095
176 NEUROPATHY PERIPHERAL 904 0.0095
177 BLOOD COUNT ABNORMAL 144 0.0095
178 LYMPHOPENIA 134 0.0095
179 PHARYNGEAL ERYTHEMA 20 0.0094
180 THROMBOPHLEBITIS 33 0.0094
181 INGUINAL HERNIA 57 0.0094
182 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 217 0.0093
183 ORAL PAIN 208 0.0093
184 HAEMATOTOXICITY 88 0.0093
185 SPINAL PAIN 108 0.0092
186 PNEUMOCYSTIS JIROVECII PNEUMONIA 92 0.0092
187 BONE LESION 33 0.0091
188 INTERVERTEBRAL DISC DISORDER 39 0.0091
189 VASCULITIS 106 0.0091
190 CHRONIC LYMPHOCYTIC LEUKAEMIA 43 0.0091
191 PNEUMONITIS 246 0.0090
192 MONOPLEGIA 39 0.0090
193 BLOOD CHLORIDE DECREASED 23 0.0089
194 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34 0.0089
195 ALOPECIA 1738 0.0088
196 RECURRENT CANCER 36 0.0088
197 SPLENOMEGALY 103 0.0088
198 HYPERHIDROSIS 1128 0.0087
199 THROMBOCYTOSIS 32 0.0087
200 DIFFUSE LARGE B-CELL LYMPHOMA 67 0.0087
201 EXPIRED DEVICE USED 28 0.0084
202 ODYNOPHAGIA 50 0.0084
203 LIVER ABSCESS 27 0.0083
204 EJECTION FRACTION DECREASED 128 0.0082
205 RED CELL DISTRIBUTION WIDTH INCREASED 34 0.0082
206 ABDOMINAL RIGIDITY 22 0.0081
207 HYPOALBUMINAEMIA 63 0.0081
208 METASTASES TO SPINE 27 0.0080
209 ATYPICAL PNEUMONIA 24 0.0080
210 MONOCYTE COUNT INCREASED 29 0.0080
211 PARONYCHIA 35 0.0080
212 BACTERAEMIA 94 0.0079
213 NAIL DISORDER 69 0.0079
214 ACUTE RESPIRATORY DISTRESS SYNDROME 138 0.0078
215 TRANSFUSION 81 0.0077
216 VENOOCCLUSIVE LIVER DISEASE 38 0.0077
217 BACTERIAL SEPSIS 25 0.0077
218 NAIL DISCOLOURATION 30 0.0076
219 COLORECTAL CANCER METASTATIC 18 0.0076
220 ANAEMIA 1443 0.0076
221 BODY TEMPERATURE INCREASED 152 0.0074
222 ORAL INTAKE REDUCED 18 0.0074
223 PLATELET COUNT ABNORMAL 45 0.0074
224 CANCER PAIN 19 0.0074
225 HYPOKALAEMIA 340 0.0074
226 VARICOSE VEIN 38 0.0074
227 BREAST CANCER METASTATIC 79 0.0073
228 CLOSTRIDIUM DIFFICILE COLITIS 78 0.0073
229 CANDIDA INFECTION 124 0.0073
230 FIBRIN D DIMER INCREASED 26 0.0073
231 ESCHERICHIA INFECTION 60 0.0073
232 INTERCEPTED PRODUCT STORAGE ERROR 26 0.0073
233 PYREXIA 2519 0.0073
234 MYELODYSPLASTIC SYNDROME 105 0.0073
235 BLOOD LACTATE DEHYDROGENASE INCREASED 115 0.0073
236 POLYNEUROPATHY 86 0.0072
237 PNEUMOCYSTIS JIROVECI PNEUMONIA 16 0.0072
238 PRODUCT DOSE OMISSION 465 0.0071
239 METASTASES TO MENINGES 16 0.0070
240 LYMPHADENOPATHY 246 0.0069
241 TUMOUR LYSIS SYNDROME 61 0.0069
242 DERMATITIS ACNEIFORM 42 0.0069
243 BONE MARROW FAILURE 140 0.0069
244 SEPSIS 763 0.0068
245 HYPOMAGNESAEMIA 95 0.0068
246 TACHYARRHYTHMIA 17 0.0068
247 MUSCULOSKELETAL CHEST PAIN 105 0.0068
248 SEPTIC SHOCK 295 0.0068
249 NEUTROPHILIA 38 0.0067
250 RHEUMATOID NODULE 18 0.0065
251 HAEMOGLOBIN ABNORMAL 42 0.0065
252 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 461 0.0065
253 B-CELL LYMPHOMA 22 0.0065
254 PLATELET COUNT DECREASED 688 0.0064
255 TENDERNESS 67 0.0064
256 HYPOXIA 226 0.0064
257 ENTERITIS 41 0.0064
258 HYPERVENTILATION 37 0.0064
259 HAEMATOCRIT DECREASED 126 0.0063
260 ESCHERICHIA URINARY TRACT INFECTION 27 0.0063
261 DEVICE DEFECTIVE 110 0.0063
262 CYTOKINE RELEASE SYNDROME 127 0.0063
263 HYPERURICAEMIA 26 0.0063
264 GASTROINTESTINAL TOXICITY 30 0.0062
265 C-REACTIVE PROTEIN INCREASED 224 0.0062
266 STOMATITIS 372 0.0061
267 PYODERMA GANGRENOSUM 22 0.0061
268 VENOUS THROMBOSIS 24 0.0061
269 PNEUMONIA FUNGAL 24 0.0061
270 PSEUDOMONAS INFECTION 52 0.0061
271 ENTEROCOLITIS 35 0.0061
272 RENAL CYST 48 0.0060
273 ACUTE MYELOID LEUKAEMIA 94 0.0060
274 ONYCHOMADESIS 25 0.0060
275 OESOPHAGITIS 65 0.0059
276 BLOOD ALKALINE PHOSPHATASE INCREASED 146 0.0059
277 METASTASES TO LIVER 103 0.0059
278 METASTASES TO BONE 96 0.0058
279 CACHEXIA 30 0.0058
280 MUSCULOSKELETAL PAIN 305 0.0058
281 FLUID INTAKE REDUCED 29 0.0058
282 DEVICE RELATED INFECTION 89 0.0058
283 ACTINIC KERATOSIS 15 0.0058
284 OESOPHAGEAL CANDIDIASIS 23 0.0058
285 CANDIDIASIS 23 0.0057
286 APPLICATION SITE ERYTHEMA 150 0.0057
287 LUNG CONSOLIDATION 16 0.0057
288 WOUND SECRETION 22 0.0056
289 STREPTOCOCCAL INFECTION 31 0.0056
290 HYPOPHOSPHATAEMIA 41 0.0055
291 CHEST X-RAY ABNORMAL 17 0.0055
292 METASTASES TO LUNG 64 0.0055
293 HICCUPS 45 0.0055
294 HOSPITALISATION 842 0.0055
295 HYDRONEPHROSIS 41 0.0055
296 UNEVALUABLE EVENT 412 0.0054
297 DEHYDRATION 725 0.0054
298 LYMPHOMA 84 0.0054
299 BLOOD CREATININE DECREASED 17 0.0054
300 TERMINAL STATE 36 0.0054
301 EXTRAVASATION 22 0.0053
302 METASTATIC NEOPLASM 23 0.0053
303 HEPATIC LESION 23 0.0053
304 LYMPHOCYTE COUNT DECREASED 94 0.0053
305 NEOPLASM RECURRENCE 18 0.0053
306 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46 0.0053
307 APPLICATION SITE REACTION 37 0.0053
308 ORGANISING PNEUMONIA 26 0.0052
309 COLITIS 195 0.0051
310 PLEURAL EFFUSION 313 0.0051
311 HYPOPHAGIA 131 0.0051
312 BLOOD DISORDER 41 0.0051
313 PROTEIN TOTAL DECREASED 19 0.0050
314 FAILURE TO THRIVE 26 0.0050
315 HYPERTHERMIA 38 0.0050
316 ERYSIPELAS 25 0.0050
317 LOOSE TOOTH 16 0.0050
318 GENERAL PHYSICAL HEALTH DETERIORATION 573 0.0049
319 CLOSTRIDIUM DIFFICILE INFECTION 108 0.0049
320 RED BLOOD CELL COUNT DECREASED 141 0.0049
321 POOR PERIPHERAL CIRCULATION 21 0.0049
322 PERFORMANCE STATUS DECREASED 23 0.0049
323 DEVICE MECHANICAL ISSUE 67 0.0049
324 ASCITES 143 0.0049
325 GAMMA-GLUTAMYLTRANSFERASE INCREASED 107 0.0048
326 WRONG DRUG ADMINISTERED 43 0.0048
327 MOUTH ULCERATION 101 0.0048
328 SINUS TACHYCARDIA 68 0.0048
329 ENTEROCOCCAL INFECTION 23 0.0048
330 DISEASE PROGRESSION 563 0.0048
331 HAEMOGLOBIN DECREASED 488 0.0047
332 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 39 0.0047
333 RESPIRATORY FAILURE 340 0.0047
334 GINGIVAL PAIN 37 0.0046
335 AGRANULOCYTOSIS 86 0.0046
336 INTERSTITIAL LUNG DISEASE 224 0.0046
337 THERAPY PARTIAL RESPONDER 72 0.0046
338 CYTOPENIA 56 0.0046
339 HYPERBILIRUBINAEMIA 47 0.0045
340 HYPERGLYCAEMIA 165 0.0045
341 ABDOMINAL ABSCESS 20 0.0045
342 INJURY ASSOCIATED WITH DEVICE 92 0.0045
343 CATHETER SITE INFECTION 17 0.0045
344 BACK PAIN 1041 0.0045
345 INFECTION 647 0.0045
346 SKIN INFECTION 50 0.0045
347 UROSEPSIS 41 0.0044
348 SPUTUM DISCOLOURED 42 0.0044
349 ILEUS 55 0.0044
350 CAROTID ARTERY OCCLUSION 16 0.0044
351 NON-SMALL CELL LUNG CANCER 21 0.0044
352 NIGHT SWEATS 141 0.0044
353 ORAL DISORDER 32 0.0044
354 PAIN IN JAW 123 0.0043
355 OFF LABEL USE 3796 0.0043
356 DYSPNOEA EXERTIONAL 163 0.0043
357 INTRACRANIAL PRESSURE INCREASED 24 0.0043
358 POLYDIPSIA 17 0.0043
359 POOR QUALITY DEVICE USED 43 0.0043
360 INTESTINAL PERFORATION 48 0.0043
361 LACRIMATION INCREASED 129 0.0043
362 HYPERAESTHESIA 35 0.0043
363 PULMONARY CONGESTION 56 0.0042
364 BLEPHARITIS 17 0.0042
365 LUNG INFECTION 65 0.0042
366 INJECTION SITE DISCOMFORT 44 0.0042
367 RASH MACULO-PAPULAR 93 0.0042
368 GASTROENTERITIS 61 0.0042
369 PULMONARY EMBOLISM 397 0.0042
370 LARGE INTESTINE PERFORATION 29 0.0042
371 HYPOCALCAEMIA 79 0.0042
372 NEOPLASM PROGRESSION 145 0.0042
373 BLOOD URIC ACID INCREASED 24 0.0042
374 ELECTROLYTE IMBALANCE 48 0.0041
375 NO THERAPEUTIC RESPONSE 50 0.0041
376 LABORATORY TEST ABNORMAL 121 0.0041
377 SENSORY LOSS 33 0.0041
378 SUPRAVENTRICULAR TACHYCARDIA 39 0.0041
379 SKIN TOXICITY 23 0.0041
380 MYALGIA 690 0.0041
381 DECUBITUS ULCER 33 0.0040
382 PROCTALGIA 26 0.0040
383 CELLULITIS 203 0.0040
384 APPLICATION SITE IRRITATION 50 0.0040
385 MYOCARDITIS 46 0.0040
386 TONGUE DISORDER 29 0.0040
387 BLOOD CALCIUM DECREASED 45 0.0040
388 CIRCULATORY COLLAPSE 68 0.0040
389 LEFT VENTRICULAR HYPERTROPHY 17 0.0040
390 TUMOUR MARKER INCREASED 19 0.0040
391 HYPONATRAEMIA 222 0.0039
392 HYPOVOLAEMIA 23 0.0039
393 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
394 TRICUSPID VALVE INCOMPETENCE 31 0.0039
395 SMALL INTESTINAL OBSTRUCTION 48 0.0039
396 DECREASED APPETITE 905 0.0039
397 HYPERCALCAEMIA 48 0.0039
398 SPINAL OSTEOARTHRITIS 34 0.0039
399 ROSACEA 18 0.0039
400 MUSCLE TWITCHING 89 0.0039
401 PULMONARY FIBROSIS 74 0.0039
402 HERPES SIMPLEX 25 0.0038
403 BLOOD TEST ABNORMAL 54 0.0038
404 CONSTIPATION 838 0.0038
405 PETECHIAE 40 0.0038
406 VEIN DISORDER 19 0.0038
407 HAEMORRHOIDS 74 0.0038
408 PRODUCTIVE COUGH 181 0.0038
409 BLOOD ALBUMIN DECREASED 30 0.0038
410 ANAL FISTULA 20 0.0037
411 FLANK PAIN 35 0.0037
412 BRAIN OEDEMA 47 0.0037
413 TEARFULNESS 16 0.0037
414 MUSCULOSKELETAL DISCOMFORT 64 0.0037
415 SINUS HEADACHE 22 0.0037
416 DEVICE DISLOCATION 161 0.0037
417 DYSGEUSIA 275 0.0037
418 TACHYPNOEA 50 0.0037
419 FULL BLOOD COUNT DECREASED 74 0.0037
420 PNEUMOTHORAX 58 0.0037
421 HYPOKINESIA 53 0.0036
422 TONSILLITIS 19 0.0036
423 EPISTAXIS 271 0.0036
424 METABOLIC DISORDER 21 0.0036
425 BRONCHOPULMONARY ASPERGILLOSIS 28 0.0036
426 APHTHOUS ULCER 28 0.0036
427 BLOOD SODIUM DECREASED 68 0.0036
428 RHINITIS ALLERGIC 16 0.0036
429 DEEP VEIN THROMBOSIS 233 0.0036
430 SYNCOPE 357 0.0036
431 ENERGY INCREASED 21 0.0036
432 GENERAL PHYSICAL CONDITION ABNORMAL 24 0.0035
433 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
434 CARDIOTOXICITY 31 0.0035
435 PRODUCT PACKAGING ISSUE 33 0.0035
436 IRON DEFICIENCY ANAEMIA 32 0.0035
437 PARAESTHESIA ORAL 50 0.0035
438 HOSPICE CARE 34 0.0034
439 FATIGUE 2673 0.0034
440 TACHYCARDIA 305 0.0034
441 BREAST MASS 23 0.0034
442 OROPHARYNGEAL PAIN 317 0.0034
443 HYPERTRIGLYCERIDAEMIA 20 0.0034
444 NEURALGIA 83 0.0034
445 PNEUMONIA 1100 0.0034
446 ANGIOPATHY 19 0.0034
447 PHARYNGOLARYNGEAL PAIN 18 0.0034
448 MENTAL STATUS CHANGES 94 0.0034
449 ATRIAL FLUTTER 27 0.0034
450 CHEST PAIN 625 0.0034
451 METASTASIS 24 0.0034
452 FACIAL PAIN 30 0.0034
453 MYELOSUPPRESSION 121 0.0034
454 INCORRECT PRODUCT STORAGE 44 0.0033
455 TOOTH ABSCESS 34 0.0033
456 ACUTE RESPIRATORY FAILURE 64 0.0033
457 HEPATITIS CHOLESTATIC 20 0.0033
458 ADVERSE REACTION 44 0.0033
459 GUILLAIN-BARRE SYNDROME 16 0.0033
460 SUDDEN DEATH 35 0.0033
461 ASPARTATE AMINOTRANSFERASE INCREASED 175 0.0033
462 PULMONARY MASS 49 0.0033
463 HYPOTHYROIDISM 105 0.0033
464 PERIORBITAL OEDEMA 17 0.0033
465 BACTERIAL INFECTION 61 0.0033
466 BLOOD POTASSIUM DECREASED 98 0.0033
467 DEATH 2804 0.0033
468 DERMATITIS CONTACT 37 0.0032
469 PLATELET COUNT INCREASED 42 0.0032
470 MALNUTRITION 36 0.0032
471 ASTHENIA 1208 0.0032
472 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
473 PELVIC PAIN 58 0.0032
474 EAR PAIN 62 0.0032
475 BONE DISORDER 58 0.0032
476 NAUSEA 2499 0.0032
477 GINGIVITIS 17 0.0031
478 TOOTHACHE 57 0.0031
479 OBESITY 50 0.0031
480 SECOND PRIMARY MALIGNANCY 26 0.0031
481 GASTROINTESTINAL INFECTION 28 0.0031
482 PHARYNGEAL OEDEMA 48 0.0031
483 GASTRITIS 82 0.0031
484 DIARRHOEA 2008 0.0031
485 JAW DISORDER 17 0.0031
486 DIVERTICULUM 22 0.0031
487 FEAR OF INJECTION 22 0.0031
488 THROMBOSIS 248 0.0031
489 RESPIRATORY DISTRESS 85 0.0031
490 TOXIC SKIN ERUPTION 31 0.0031
491 IMMUNOSUPPRESSION 27 0.0031
492 VOMITING 1438 0.0031
493 HYPOTENSION 612 0.0030
494 LOCAL SWELLING 53 0.0030
495 URINARY TRACT INFECTION 518 0.0030
496 HYPERTRANSAMINASAEMIA 21 0.0030
497 MULTI-ORGAN FAILURE 52 0.0030
498 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
499 STAPHYLOCOCCAL INFECTION 98 0.0030
500 ANAPHYLACTIC REACTION 164 0.0030
501 HEPATIC STEATOSIS 55 0.0029
502 ABDOMINAL PAIN 684 0.0029
503 HAEMATOMA 76 0.0029
504 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 137 0.0029
505 BLOOD BILIRUBIN INCREASED 79 0.0029
506 RENAL FAILURE ACUTE 124 0.0029
507 CHILLS 342 0.0029
508 OSTEONECROSIS OF JAW 72 0.0029
509 CARDIOMYOPATHY 43 0.0029
510 ADVERSE EVENT 268 0.0029
511 BREAST PAIN 31 0.0029
512 ONYCHOCLASIS 20 0.0029
513 CHOLANGITIS 18 0.0029
514 NECK PAIN 162 0.0029
515 PAIN 1777 0.0029
516 TROPONIN INCREASED 22 0.0029
517 COGNITIVE DISORDER 135 0.0029
518 MICTURITION URGENCY 33 0.0029
519 ATRIAL FIBRILLATION 281 0.0029
520 DYSPNOEA 1633 0.0029
521 ALANINE AMINOTRANSFERASE INCREASED 177 0.0029
522 DYSURIA 106 0.0029
523 PAIN IN EXTREMITY 847 0.0029
524 ARRHYTHMIA 136 0.0029
525 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 17 0.0029
526 SENSORY DISTURBANCE 46 0.0029
527 LEUKAEMIA 27 0.0029
528 GROIN PAIN 25 0.0028
529 SKIN REACTION 40 0.0028
530 LOWER RESPIRATORY TRACT INFECTION 129 0.0028
531 OEDEMA 153 0.0028
532 LUNG DISORDER 138 0.0028
533 POSTOPERATIVE WOUND INFECTION 19 0.0028
534 LIMB DISCOMFORT 87 0.0028
535 HAEMORRHAGE INTRACRANIAL 42 0.0028
536 OEDEMA PERIPHERAL 342 0.0028
537 MALIGNANT NEOPLASM PROGRESSION 287 0.0028
538 CYSTITIS 89 0.0028
539 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
540 RASH PUSTULAR 20 0.0027
541 HYPOGAMMAGLOBULINAEMIA 18 0.0027
542 MITRAL VALVE INCOMPETENCE 31 0.0027
543 PROTEINURIA 52 0.0027
544 RESTLESSNESS 100 0.0027
545 TOOTH INFECTION 36 0.0027
546 ENCEPHALOPATHY 67 0.0027
547 ANOREXIA 35 0.0027
548 APPETITE DISORDER 18 0.0027
549 NASAL DRYNESS 17 0.0027
550 OVARIAN CANCER 25 0.0027
551 DERMATITIS ALLERGIC 34 0.0027
552 CHOLECYSTITIS 32 0.0027
553 COLITIS ISCHAEMIC 18 0.0027
554 FOREIGN BODY SENSATION IN EYES 17 0.0027
555 GENERALISED OEDEMA 33 0.0027
556 PULMONARY THROMBOSIS 29 0.0027
557 PYELONEPHRITIS 23 0.0027
558 OSTEOMYELITIS 48 0.0026
559 VIRAL INFECTION 88 0.0026
560 ADRENAL INSUFFICIENCY 32 0.0026
561 GLOSSODYNIA 59 0.0026
562 DYSPHAGIA 250 0.0026
563 NEUROTOXICITY 46 0.0026
564 MOBILITY DECREASED 187 0.0026
565 PNEUMONIA ASPIRATION 65 0.0026
566 RESPIRATORY RATE INCREASED 23 0.0026
567 HAEMOLYSIS 20 0.0026
568 INFLAMMATION 133 0.0026
569 MASS 36 0.0026
570 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
571 ARTHRALGIA 1070 0.0026
572 CHEST DISCOMFORT 263 0.0026
573 ORAL HERPES 50 0.0026
574 WOUND INFECTION 28 0.0026
575 GASTROINTESTINAL INFLAMMATION 20 0.0026
576 FACE OEDEMA 43 0.0025
577 CYTOMEGALOVIRUS INFECTION 42 0.0025
578 MUSCLE SPASTICITY 31 0.0025
579 GASTROINTESTINAL DISORDER 226 0.0025
580 BEDRIDDEN 33 0.0025
581 COUGH 703 0.0025
582 RASH GENERALISED 64 0.0025
583 APPLICATION SITE VESICLES 16 0.0025
584 BLOOD CREATININE INCREASED 161 0.0025
585 ASPIRATION 27 0.0025
586 SLEEP APNOEA SYNDROME 47 0.0025
587 INFLUENZA LIKE ILLNESS 202 0.0025
588 PARAESTHESIA 382 0.0024
589 WALKING AID USER 16 0.0024
590 SUNBURN 18 0.0024
591 HAEMOPTYSIS 67 0.0024
592 HOT FLUSH 181 0.0024
593 BLOOD PRESSURE DECREASED 158 0.0024
594 MUSCULOSKELETAL DISORDER 45 0.0024
595 DISCOMFORT 144 0.0024
596 NEOPLASM 27 0.0023
597 UPPER RESPIRATORY TRACT INFECTION 108 0.0023
598 THROAT TIGHTNESS 63 0.0023
599 ULCER 37 0.0023
600 POLYURIA 19 0.0023
601 ABNORMAL FAECES 19 0.0023
602 MALAISE 1009 0.0023
603 HYPOACUSIS 99 0.0023
604 ACUTE CORONARY SYNDROME 19 0.0023
605 ANAPHYLACTIC SHOCK 59 0.0023
606 PALLOR 62 0.0023
607 DIVERTICULITIS 63 0.0023
608 RESPIRATORY TRACT INFECTION 59 0.0023
609 SKIN LESION 62 0.0023
610 EATING DISORDER 48 0.0023
611 WOUND 63 0.0023
612 SKIN FISSURES 44 0.0022
613 CEREBRAL INFARCTION 55 0.0022
614 APPLICATION SITE PRURITUS 51 0.0022
615 HYPOAESTHESIA 336 0.0022
616 RHINORRHOEA 145 0.0022
617 INTERVERTEBRAL DISC PROTRUSION 49 0.0022
618 LACERATION 21 0.0022
619 MYOSITIS 20 0.0022
620 ACUTE KIDNEY INJURY 341 0.0022
621 PERICARDIAL EFFUSION 51 0.0022
622 FEELING HOT 134 0.0022
623 FULL BLOOD COUNT ABNORMAL 23 0.0022
624 FEEDING DISORDER 44 0.0022
625 TASTE DISORDER 44 0.0022
626 SCAR 37 0.0022
627 SUBARACHNOID HAEMORRHAGE 22 0.0022
628 LETHARGY 124 0.0022
629 BLOOD UREA INCREASED 36 0.0021
630 PRESYNCOPE 52 0.0021
631 ADVERSE DRUG REACTION 192 0.0021
632 URINARY INCONTINENCE 63 0.0021
633 FEELING COLD 59 0.0021
634 EMOTIONAL DISTRESS 256 0.0021
635 APPLICATION SITE RASH 29 0.0021
636 INJECTION SITE EXTRAVASATION 26 0.0021
637 INCONTINENCE 22 0.0021
638 ABSCESS 33 0.0021
639 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
640 NEPHROPATHY TOXIC 23 0.0020
641 AGEUSIA 51 0.0020
642 SWELLING FACE 133 0.0020
643 BRAIN FOG 32 0.0020
644 WEIGHT DECREASED 569 0.0020
645 HEPATOMEGALY 20 0.0020
646 INJECTION SITE HAEMORRHAGE 162 0.0020
647 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
648 THERAPEUTIC RESPONSE DECREASED 122 0.0020
649 FLUSHING 204 0.0020
650 SLEEP DISORDER 141 0.0020
651 DENTAL CARIES 22 0.0020
652 FEELING ABNORMAL 476 0.0020
653 CONFUSIONAL STATE 321 0.0020
654 DYSPEPSIA 195 0.0020
655 FRUSTRATION TOLERANCE DECREASED 16 0.0020
656 HEPATOTOXICITY 44 0.0020
657 HYPERSENSITIVITY 365 0.0020
658 EAR DISCOMFORT 20 0.0019
659 HEMIPARESIS 33 0.0019
660 NEOPLASM MALIGNANT 130 0.0019
661 HEART RATE INCREASED 192 0.0019
662 SPINAL COMPRESSION FRACTURE 16 0.0019
663 TRANSAMINASES INCREASED 43 0.0019
664 PAIN OF SKIN 52 0.0019
665 HEPATIC FAILURE 58 0.0019
666 PURPURA 17 0.0019
667 SWOLLEN TONGUE 60 0.0019
668 TOOTH FRACTURE 21 0.0019
669 POOR QUALITY SLEEP 41 0.0019
670 SPINAL FRACTURE 38 0.0019
671 PERIPHERAL COLDNESS 26 0.0019
672 SKIN DISCOLOURATION 87 0.0019
673 IMMUNODEFICIENCY 28 0.0019
674 VAGINAL DISCHARGE 19 0.0019
675 DEAFNESS 49 0.0019
676 CARDIOMEGALY 23 0.0019
677 SHOCK 43 0.0019
678 HAEMATURIA 64 0.0019
679 HERPES ZOSTER 107 0.0019
680 SKIN HYPERPIGMENTATION 16 0.0019
681 INFUSION RELATED REACTION 123 0.0019
682 DECREASED ACTIVITY 20 0.0019
683 INCORRECT DOSE ADMINISTERED 423 0.0019
684 ERYTHEMA 379 0.0018
685 GASTRIC ULCER 35 0.0018
686 ACUTE MYOCARDIAL INFARCTION 54 0.0018
687 SKIN DISORDER 61 0.0018
688 DEVICE DIFFICULT TO USE 121 0.0018
689 THERAPY NON-RESPONDER 82 0.0018
690 IMMUNE SYSTEM DISORDER 24 0.0018
691 SKIN ULCER 47 0.0018
692 ANXIETY 517 0.0018
693 DELIRIUM 63 0.0018
694 MUSCULAR WEAKNESS 206 0.0018
695 NOCTURIA 22 0.0018
696 RASH 790 0.0018
697 DYSPHONIA 105 0.0018
698 HYPOAESTHESIA ORAL 27 0.0018
699 LIVER FUNCTION TEST ABNORMAL 52 0.0018
700 DEVICE USE ISSUE 31 0.0018
701 ABDOMINAL PAIN UPPER 364 0.0018
702 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
703 DERMATITIS 37 0.0018
704 OXYGEN SATURATION DECREASED 99 0.0018
705 HYPERLIPIDAEMIA 21 0.0018
706 POLLAKIURIA 73 0.0017
707 PNEUMONIA BACTERIAL 16 0.0017
708 PLASMA CELL MYELOMA 68 0.0017
709 ACCIDENTAL UNDERDOSE 25 0.0017
710 HYPERTHYROIDISM 25 0.0017
711 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 90 0.0017
712 DIARRHOEA HAEMORRHAGIC 16 0.0017
713 HYPOTONIA 17 0.0017
714 ARTERIOSCLEROSIS 16 0.0017
715 CARDIAC FAILURE 136 0.0017
716 PHARYNGITIS 21 0.0017
717 DIALYSIS 24 0.0017
718 BLOOD URINE PRESENT 32 0.0017
719 EMPHYSEMA 17 0.0017
720 BRONCHOSPASM 24 0.0017
721 COAGULOPATHY 28 0.0017
722 INSOMNIA 447 0.0017
723 ABDOMINAL DISTENSION 175 0.0017
724 ANAL INCONTINENCE 15 0.0017
725 SYRINGE ISSUE 29 0.0017
726 PULMONARY OEDEMA 74 0.0017
727 LIP SWELLING 55 0.0016
728 TEMPERATURE INTOLERANCE 17 0.0016
729 OSTEOPENIA 25 0.0016
730 PRODUCT ADMINISTRATION ERROR 33 0.0016
731 LUNG NEOPLASM MALIGNANT 67 0.0016
732 FUNGAL INFECTION 54 0.0016
733 DYSSTASIA 47 0.0016
734 COVID-19 PNEUMONIA 19 0.0016
735 LOSS OF CONSCIOUSNESS 206 0.0016
736 MUSCLE TIGHTNESS 26 0.0016
737 SURGERY 94 0.0016
738 ATAXIA 19 0.0016
739 PERITONITIS 33 0.0016
740 COLD SWEAT 28 0.0016
741 RECTAL HAEMORRHAGE 68 0.0016
742 RENAL FAILURE 210 0.0016
743 BRONCHITIS 117 0.0016
744 RESPIRATORY DISORDER 47 0.0016
745 THIRST 28 0.0016
746 SPEECH DISORDER 82 0.0016
747 MUSCLE SPASMS 287 0.0016
748 EXTRA DOSE ADMINISTERED 63 0.0016
749 ORTHOSTATIC HYPOTENSION 27 0.0015
750 RETCHING 33 0.0015
751 ABDOMINAL PAIN LOWER 39 0.0015
752 DRUG TOXICITY 21 0.0015
753 HYPERKALAEMIA 54 0.0015
754 GINGIVAL BLEEDING 21 0.0015
755 HEADACHE 961 0.0015
756 VENTRICULAR TACHYCARDIA 25 0.0015
757 RASH PRURITIC 82 0.0015
758 FALL 502 0.0015
759 NERVOUS SYSTEM DISORDER 47 0.0015
760 URTICARIA 252 0.0015
761 PALPITATIONS 176 0.0015
762 IMPAIRED HEALING 49 0.0015
763 LOCALISED INFECTION 36 0.0015
764 INTESTINAL OBSTRUCTION 56 0.0015
765 NERVOUSNESS 76 0.0015
766 TOOTH EXTRACTION 18 0.0014
767 RASH ERYTHEMATOUS 69 0.0014
768 ORAL DISCOMFORT 20 0.0014
769 DRUG EFFECT INCOMPLETE 52 0.0014
770 DIZZINESS 713 0.0014
771 RASH PAPULAR 32 0.0014
772 MALIGNANT MELANOMA 19 0.0014
773 MELAENA 31 0.0014
774 ISCHAEMIC STROKE 25 0.0014
775 LIVER FUNCTION TEST INCREASED 30 0.0014
776 HAEMATOCHEZIA 77 0.0014
777 CONTUSION 134 0.0014
778 GASTROINTESTINAL HAEMORRHAGE 116 0.0014
779 ILL-DEFINED DISORDER 84 0.0014
780 SCIATICA 22 0.0014
781 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 248 0.0014
782 CYST 17 0.0014
783 SKIN EXFOLIATION 115 0.0014
784 FLUID RETENTION 69 0.0014
785 CONJUNCTIVITIS 25 0.0013
786 GAIT DISTURBANCE 257 0.0013
787 HEPATIC FUNCTION ABNORMAL 50 0.0013
788 ABASIA 33 0.0013
789 CHROMATURIA 30 0.0013
790 DRY SKIN 177 0.0013
791 RASH MACULAR 46 0.0013
792 INCORRECT ROUTE OF DRUG ADMINISTRATION 47 0.0013
793 MEDICATION ERROR 73 0.0013
794 DISORIENTATION 52 0.0013
795 OSTEONECROSIS 43 0.0013
796 IRRITABLE BOWEL SYNDROME 28 0.0013
797 TOOTH LOSS 27 0.0013
798 CHOLESTASIS 25 0.0013
799 DRUG ERUPTION 23 0.0013
800 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
801 FAECES DISCOLOURED 28 0.0013
802 SARS-COV-2 TEST POSITIVE 17 0.0013
803 CEREBRAL HAEMORRHAGE 46 0.0013
804 EYE DISORDER 42 0.0013
805 PHOTOPHOBIA 24 0.0013
806 URINARY RETENTION 42 0.0013
807 DRY MOUTH 102 0.0013
808 ANGINA PECTORIS 36 0.0013
809 DEMENTIA 35 0.0013
810 LIMB INJURY 34 0.0013
811 INJECTION SITE PAIN 383 0.0012
812 PULMONARY HYPERTENSION 26 0.0012
813 ECZEMA 65 0.0012
814 TINNITUS 57 0.0012
815 FLUID OVERLOAD 18 0.0012
816 FEAR 33 0.0012
817 NODULE 16 0.0012
818 CARDIAC ARREST 100 0.0012
819 EPILEPSY 37 0.0012
820 BLOOD PRESSURE ABNORMAL 24 0.0012
821 PANCREATITIS ACUTE 27 0.0012
822 WHEEZING 71 0.0012
823 HYPERSOMNIA 34 0.0012
824 JOINT STIFFNESS 31 0.0012
825 HEPATIC ENZYME INCREASED 80 0.0012
826 CARDIAC FAILURE CONGESTIVE 94 0.0012
827 HYPERTENSION 247 0.0012
828 MEMORY IMPAIRMENT 160 0.0012
829 METABOLIC ACIDOSIS 37 0.0012
830 PERIPHERAL SWELLING 178 0.0012
831 ABDOMINAL DISCOMFORT 193 0.0011
832 PHOTOSENSITIVITY REACTION 19 0.0011
833 CARDIO-RESPIRATORY ARREST 48 0.0011
834 APHONIA 16 0.0011
835 PANCREATIC CARCINOMA 33 0.0011
836 EMOTIONAL DISORDER 35 0.0011
837 DEPRESSED MOOD 60 0.0011
838 SWELLING 106 0.0011
839 LIVER DISORDER 50 0.0011
840 INFLUENZA 125 0.0011
841 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
842 SUBDURAL HAEMATOMA 16 0.0011
843 SINUS DISORDER 22 0.0011
844 BALANCE DISORDER 96 0.0011
845 NASAL CONGESTION 65 0.0011
846 SOMNOLENCE 222 0.0011
847 PREMATURE BABY 33 0.0011
848 VISUAL ACUITY REDUCED 36 0.0011
849 MENTAL DISORDER 47 0.0011
850 TOOTH DISORDER 24 0.0011
851 PRODUCT USE IN UNAPPROVED INDICATION 266 0.0011
852 TREMOR 178 0.0011
853 ANGIOEDEMA 47 0.0011
854 RENAL IMPAIRMENT 88 0.0010
855 INCREASED APPETITE 20 0.0010
856 OSTEOPOROSIS 43 0.0010
857 DRY EYE 52 0.0010
858 JAUNDICE 28 0.0010
859 FLATULENCE 59 0.0010
860 ERUCTATION 20 0.0010
861 BLISTER 58 0.0010
862 BLOOD GLUCOSE ABNORMAL 19 0.0010
863 APHASIA 31 0.0010
864 HAEMATEMESIS 26 0.0010
865 RIB FRACTURE 21 0.0010
866 CYANOSIS 16 0.0010
867 CARDIAC DISORDER 95 0.0010
868 BURNING SENSATION 71 0.0010
869 OCULAR HYPERAEMIA 48 0.0010
870 HEAD INJURY 32 0.0010
871 JOINT SWELLING 122 0.0010
872 UNRESPONSIVE TO STIMULI 26 0.0010
873 RESPIRATORY TRACT CONGESTION 16 0.0010
874 CHOLELITHIASIS 33 0.0010
875 GOUT 18 0.0010
876 SINUSITIS 102 0.0010
877 VISUAL IMPAIRMENT 123 0.0010
878 DYSARTHRIA 37 0.0010
879 INTENTIONAL PRODUCT MISUSE 86 0.0010
880 EYE SWELLING 36 0.0010
881 DISABILITY 19 0.0010
882 DISEASE RECURRENCE 45 0.0009
883 COVID-19 165 0.0009
884 NASOPHARYNGITIS 173 0.0009
885 SNEEZING 21 0.0009
886 PRURITUS 359 0.0009
887 DRUG INTOLERANCE 90 0.0009
888 HEART RATE IRREGULAR 21 0.0009
889 GAIT INABILITY 31 0.0009
890 TOXICITY TO VARIOUS AGENTS 156 0.0009
891 PRURITUS GENERALISED 20 0.0009
892 INJURY 65 0.0009
893 DIPLOPIA 24 0.0009
894 EOSINOPHILIA 16 0.0009
895 CONVULSION 52 0.0009
896 GASTRIC DISORDER 31 0.0009
897 VISION BLURRED 124 0.0009
898 MUSCULOSKELETAL STIFFNESS 79 0.0009
899 HAEMORRHAGE 93 0.0009
900 VERTIGO 54 0.0009
901 POST PROCEDURAL COMPLICATION 17 0.0009
902 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
903 BREAST CANCER 82 0.0009
904 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
905 RENAL DISORDER 40 0.0009
906 PANCREATITIS 45 0.0009
907 OSTEOARTHRITIS 36 0.0008
908 HYPOGLYCAEMIA 41 0.0008
909 ARTHRITIS 66 0.0008
910 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
911 DRUG INTERACTION 131 0.0008
912 THROAT IRRITATION 37 0.0008
913 DRUG ADMINISTRATION ERROR 25 0.0008
914 EXPOSURE VIA SKIN CONTACT 21 0.0008
915 STEVENS-JOHNSON SYNDROME 18 0.0008
916 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
917 VAGINAL HAEMORRHAGE 35 0.0008
918 IMPAIRED WORK ABILITY 17 0.0008
919 PROCEDURAL PAIN 22 0.0008
920 CARDIOVASCULAR DISORDER 20 0.0008
921 HEPATITIS 20 0.0008
922 DEPRESSION 177 0.0008
923 DRUG INEFFECTIVE 1018 0.0008
924 RHABDOMYOLYSIS 32 0.0008
925 NEPHROLITHIASIS 35 0.0008
926 INJECTION SITE REACTION 52 0.0008
927 MIGRAINE 71 0.0007
928 MYOCARDIAL INFARCTION 128 0.0007
929 SEIZURE 84 0.0007
930 CORONARY ARTERY DISEASE 22 0.0007
931 ANHEDONIA 19 0.0007
932 CONDITION AGGRAVATED 211 0.0007
933 EYE PAIN 38 0.0007
934 BLOOD PRESSURE FLUCTUATION 16 0.0007
935 PRODUCT USE ISSUE 125 0.0007
936 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
937 DIABETES MELLITUS 50 0.0007
938 INJECTION SITE BRUISING 52 0.0007
939 LACTIC ACIDOSIS 21 0.0006
940 AMNESIA 42 0.0006
941 BRADYCARDIA 34 0.0006
942 BLINDNESS 26 0.0006
943 GASTRIC CANCER 16 0.0006
944 ILLNESS 65 0.0006
945 AGITATION 46 0.0006
946 ROAD TRAFFIC ACCIDENT 26 0.0006
947 OVERDOSE 133 0.0006
948 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
949 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
950 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
951 BLOOD PRESSURE INCREASED 90 0.0006
952 COMA 28 0.0006
953 INJECTION SITE RASH 18 0.0006
954 CEREBROVASCULAR ACCIDENT 99 0.0006
955 PANIC ATTACK 21 0.0006
956 WEIGHT INCREASED 128 0.0006
957 INJECTION SITE MASS 21 0.0006
958 HIP FRACTURE 18 0.0006
959 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
960 DRUG-INDUCED LIVER INJURY 17 0.0005
961 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
962 HALLUCINATION 40 0.0005
963 FOETAL EXPOSURE DURING PREGNANCY 43 0.0005
964 ASTHMA 59 0.0005
965 DISTURBANCE IN ATTENTION 28 0.0005
966 BLOOD GLUCOSE INCREASED 96 0.0005
967 ACCIDENTAL OVERDOSE 18 0.0005
968 ARTHROPATHY 27 0.0005
969 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
970 EYE PRURITUS 16 0.0005
971 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
972 CRYING 17 0.0005
973 INJECTION SITE ERYTHEMA 58 0.0005
974 SKIN IRRITATION 21 0.0005
975 CATARACT 27 0.0005
976 THERAPY INTERRUPTED 32 0.0004
977 DYSKINESIA 18 0.0004
978 IRRITABILITY 26 0.0004
979 THERAPY CESSATION 22 0.0004
980 PRODUCT DOSE OMISSION ISSUE 126 0.0004
981 DRUG ABUSE 35 0.0004
982 EYE IRRITATION 24 0.0004
983 INJECTION SITE SWELLING 31 0.0004
984 DRUG EFFECT DECREASED 21 0.0004
985 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
986 NO ADVERSE EVENT 68 0.0004
987 SKIN BURNING SENSATION 25 0.0003
988 ACNE 25 0.0003
989 CHRONIC KIDNEY DISEASE 25 0.0003
990 TREATMENT FAILURE 27 0.0003
991 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
992 PROSTATE CANCER 22 0.0003
993 SUICIDAL IDEATION 19 0.0002
994 RHEUMATOID ARTHRITIS 19 0.0002